NEW YORK (GenomeWeb News) – Quest Diagnostics and the University of California, San Francisco today announced a collaboration to develop diagnostic tests to advance precision medicine.

The alliance will initially take aim at autism, oncology, neurology, and women's health, and has as its underlying goal to enable "holistic and integrated diagnostic solutions that close gaps in care or enable new clinical value."

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Chan Zuckerberg Initiative is investing in Cold Spring Harbor Laboratory's BioRxiv.

A study appearing in PLOS One finds that shortened consent forms don't affect clinical trial participants' understanding of the study.

The National Security Agency monitored signal intelligence for signs of "nefarious" genetic engineering projects, Gizmodo reports.

In Nature this week: barley genome sequenced, method for genotyping and phasing short tandem repeats, and more.